Bone healing in children with osteogenesis imperfecta treated with bisphosphonates

Journal of Pediatric Orthopaedics

Volumn 25, Issue 3, 2005, Pages 332-335

  Pizones, Javier ^a   Plotkin, Horacio ^b   Parra Garcia, Jose Ignacio ^a   Alvarez, Patricia ^a   Gutierrez, Pilar ^a   Bueno, Ana ^a   Fernandez Arroyo, Antonio ^a  

^a HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^b Children's Hospital Omaha   (United States)

Author keywords

Alendronate; Children; Osteogenesis imperfecta; Pamidronate

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; FOLLOW UP; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE NONUNION; HUMAN; MALE; OSTEOGENESIS IMPERFECTA; OSTEOTOMY; PATHOLOGIC FRACTURE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REOPERATION; SCHOOL CHILD; SIDE EFFECT; SKIN INFECTION; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; FRACTURE FIXATION; FRACTURE HEALING; FRACTURES, SPONTANEOUS; HUMANS; MALE; OSTEOGENESIS IMPERFECTA; TREATMENT OUTCOME;

EID: 17844364433     PISSN: 02716798     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.bpo.0000152940.10487.c9     Document Type: Article

References (33)

1. Plotkin H, Primorac D, Rowe D. Osteogenesis imperfecta. In: Glorieux F, Pettifor J, Juppner J, eds. Pediatric Bone: Biology and Disease. San Diego: Elsevier Science, 2003.
2. Albright JA. Systemic treatment of osteogenesis imperfecta. Clin Orthop. 1981;88-96.
3. Castells S. New approaches to treatment of osteogenesis imperfecta. Clin Orthop. 1973;93:239-249.
4. Nishi Y, Hamamoto K, Kajiyama M, et al. Effect of long-term calcitonin therapy by injection and nasal spray on the incidence of fractures in osteogenesis imperfecta. J Pediatr. 1992;121:477-480.
5. Marini JC, Hopkins E, Glorieux FH, et al. Positive linear growth and bone responses to growth hormone treatment in children with types III and IV osteogenesis imperfecta: high predictive value of carboxyterminal propeptide of type I procollagen. J Bone Miner Res. 2003;18:237-243.
6. Plotkin H, Rauch F, Bishop N, et al. Pamidronate treatment of severe osteogenesis imperfecta in children under three years of age. J Clin Endocrinol Metab. 2000;85:1846-1850.
7. Rauch F, Plotkin H, Travers R, et al. Osteogenesis imperfecta types I, III and IV: effect of pamidronate therapy on bone and mineral metabolism. J Clin Endocrinol Metab. 2003;88:986-992.
8. Rauch F, Travers R, Plotkin H, et al. The effects of intravenous pamidronate on the bone tissue of children and adolescents with osteogenesis imperfecta. J Clin Invest. 2002;110:1293-1299.
9. Astrom E, Soderhall S. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta. Acta Paediatr. 1998;87:64-68.
10. Bembi B, Parma A, Bottega M, et al. Intravenous pamidronate treatment in osteogenesis imperfecta. J Pediatr. 1997;131:622-625.
11. Glorieux FH, Bishop NJ, Plotkin H, et al. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta. N Engl J Med. 1998;339:947-952.
12. Millar EA. Observation on the surgical management of osteogenesis imperfecta. Clin Orthop. 1981;159:154-156.
13. Engelbert RH, Helders PJ, Keessen W, et al. Intramedullary rodding in type III osteogenesis imperfecta. Effects on neuromotor development in 10 children. Acta Orthop Scand. 1995;66:361-364.
14. McHale KA, Tenuta JJ, Tosi LL, et al. Percutaneous intramedullary fixation of long bone deformity in severe osteogenesis imperfecta. Clin Orthop. 1994;242-248.
15. Kishore M, Benjamin J. Intramedullary rodding in osteogenesis imperfecta. J Pediatr Orthop. 2000;20:267-273.
16. Niemann KM. Surgical treatment of the tibia in osteogenesis imperfecta. Clin Orthop. 1981;159:134-140.
17. Ring D, Jupiter JB, Labropoulos PK, et al. Treatment of deformity of the lower limb in adults who have osteogenesis imperfecta. J Bone Joint Surg [Am]. 1996;78:220-225.
18. Gamble JG, Strudwick WJ, Rinsky LA, et al. Complications of intramedullary rods in osteogenesis imperfecta: Bailey-Dubow rods versus nonelongating rods. J Pediatr Orthop. 1988;8:645-649.
19. Janus GJM, Vanpaemel L, Engelbert RHH, et al. Complications of the Bailey-Dubow elongating nail in osteogenesis imperfecta: 34 children with 110 nails. J Pediatr Orthop B. 1999;8:203-207.
20. Luhmann SJ, Sheridan JJ, Capelli AM, et al. Management of lower-extremity deformities in osteogenesis imperfecta with extensible intramedullary rod technique: a 20-year experience. J Pediatr Orthop. 1998;18:88-94.
21. Wilkinson JM, Scott BW, Clarke AM, et al. Surgical stabilisation of the lower limb in osteogenesis imperfecta using the Sheffield telescopic intramedullary rod system. J Bone Joint Surg [Br]. 1998;80:999-1004.
22. Henderson RC, Lark RK, Kecskemethy H, et al. Bisphosphonates to treat osteopenia in children with quadriplegic cerebral palsy: a randomized, placebo-controlled clinical trial. J Pediatr. 2002; 141:644-651.
23. Plotkin LI, Parfitt AM, Manolagas SC, et al. Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin. J Clin Invest. 1999;104:1363-1374.
24. Halasy-Nagy JM, Rodan GA, Reszka AA. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone. 2001;29:553-559.
25. Hughes DE, Wright KR, Uy HL, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995;10:1478-1487.
26. Zeitlin L, Rauch F, Plotkin H, et al. Height and weight development during four years of therapy with cyclical intravenous pamidronate in children and adolescents with osteogenesis imperfecta types I, III and IV. Pediatrics. 2003;111:1030-1036.
27. Brumsen C, Hamdy NA, Papapoulos SE. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Balt). 1997;76:266-283.
28. Li YH, Chow W, Leong JC. The Sofield-Millar operation in osteogenesis imperfecta. A modified technique. J Bone Joint Surg [Br]. 2000;82: 11-16.
29. Nyman MT, Gao T, Lindholm TC, et al. Healing of a tibial double osteotomy is modified by clodronate administration. Arch Orthop Trauma Surg. 1996;115:111-114.
30. Peter CP, Cook WO, Nunamaker DM, et al. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res. 1996;14:74-79.
31. Li C, Mori S, Li J, et al. Long-term effect of incadronate disodium (ym-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16:429-436.
32. Lenehan TM, Balligand M, Nunamaker DM, et al. Effect of EHDP on fracture healing in dogs. J Orthop Res. 1985;3:499-507.
33. Gamble JG, Rinsky LA, Strudwick J, et al. Non-union of fractures in children who have osteogenesis imperfecta. J Bone Joint Surg [Am]. 1988;70:439-443.